-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TxMpAcs0IWz9R/NYbDY35r5NW0Z8hMG0EnCZAHv9DHX8Y25yaVWEu0yL5FUzxhIq p7XjWpW8ELWL8XXC71gv3Q== 0001104659-10-027407.txt : 20100511 0001104659-10-027407.hdr.sgml : 20100511 20100510205151 ACCESSION NUMBER: 0001104659-10-027407 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100504 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20100511 DATE AS OF CHANGE: 20100510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 10818769 BUSINESS ADDRESS: STREET 1: 101 GORDON DR STREET 2: P O BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 101 GORDON DRIVE STREET 2: PO BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 8-K 1 a10-9870_18k.htm 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported) – May 4, 2010

 

 

WEST PHARMACEUTICAL SERVICES, INC.

(Exact name of registrant as specified in its charter)

 

 

Pennsylvania

 

1-8036

 

23-1210010

(State or other jurisdiction
of Incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

101 Gordon Drive, PO Box 645,
Lionville, PA

 

19341-0645

(Address of principal executive offices)

 

(Zip Code)

 

(610) 594-2900

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

West Pharmaceutical Services, Inc. held its annual meeting of shareholders on May 4, 2010, and the following matters were voted on at that meeting:

 

1.             The election of the following Class II directors, who will serve for a term of three years and until their successors are elected and qualified:

 

Name

 

For

 

Withheld

 

Thomas W. Hofmann

 

26,283,870

 

472,346

 

L. Robert Johnson

 

26,059,278

 

696,938

 

John P. Neafsey

 

26,056,928

 

699,288

 

Geoffrey F. Worden

 

26,059,513

 

696,704

 

 

2.             The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2010 fiscal year was approved by the following vote: For, 29,186,931; Against, 41,997; Abstain, 6,590; Broker Non-Vote,  -0-.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

WEST PHARMACEUTICAL SERVICES, INC.

 

 

 

 

 

 

/s/ John R. Gailey III

 

 

John R. Gailey III, Vice President, General

 

 

Counsel and Secretary

 

 

May 10, 2010

 

3

 -----END PRIVACY-ENHANCED MESSAGE-----